annb0t
Top 20
Immutep Limited
SYDNEY, AUSTRALIA, May 18, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutepâ or âthe Companyâ), a biotechnology company developing novel LAG-3-related immunotherapy treatments for cancer and autoimmune diseases, announced today the appointment of four new members to the Companyâs Clinical Advisory Board (CAB).
The CAB serves as a strategic resource to Immutep as the Company continues to advance its pipeline of LAG-3 programs, inclu...
>>> Read more: Immutep Appoints Leading Oncologists to its Clinical Advisory Board
SYDNEY, AUSTRALIA, May 18, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutepâ or âthe Companyâ), a biotechnology company developing novel LAG-3-related immunotherapy treatments for cancer and autoimmune diseases, announced today the appointment of four new members to the Companyâs Clinical Advisory Board (CAB).
The CAB serves as a strategic resource to Immutep as the Company continues to advance its pipeline of LAG-3 programs, inclu...
>>> Read more: Immutep Appoints Leading Oncologists to its Clinical Advisory Board
